HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maurizio Raiteri Selected Research

D-Aspartic Acid (D Aspartate)

10/2010Alterations of glutamate release in the spinal cord of mice with experimental autoimmune encephalomyelitis.
10/2005Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis.
11/2004Glutamate efflux from human cerebrocortical slices during ischemia: vesicular-like mode of glutamate release and sensitivity to A(2A) adenosine receptor blockade.
5/2004Excessive and precocious glutamate release in a mouse model of amyotrophic lateral sclerosis.
8/2003Sensitivity to selective adenosine A1 and A2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices.
3/2003Activation of a glycine transporter on spinal cord neurons causes enhanced glutamate release in a mouse model of amyotrophic lateral sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maurizio Raiteri Research Topics

Disease

4Ischemia
10/2011 - 08/2003
4Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2006 - 03/2003
2Parkinson Disease (Parkinson's Disease)
06/2006 - 03/2005
2Brain Ischemia (Cerebral Ischemia)
11/2004 - 08/2003
1Epilepsy (Aura)
10/2011
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2010
1Anxiety Disorders (Anxiety Disorder)
01/2010
1Nervous System Diseases (Neurological Disorders)
08/2008
1Mental Disorders (Mental Disorder)
06/2006
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2005

Drug/Important Bio-Agent (IBA)

6D-Aspartic Acid (D Aspartate)IBA
10/2010 - 03/2003
6Glutamic Acid (Glutamate)FDA Link
10/2010 - 03/2003
5Glycine (Aminoacetic Acid)FDA LinkGeneric
10/2011 - 03/2003
5gamma-Aminobutyric Acid (GABA)IBA
08/2010 - 03/2003
2IonsIBA
08/2010 - 08/2003
2Neurotransmitter Agents (Neurotransmitter)IBA
08/2010 - 06/2006
2Tetrodotoxin (Tetradotoxin)IBA
11/2004 - 08/2003
25- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA
11/2004 - 08/2003
2Adenosine (Adenocard)FDA LinkGeneric
11/2004 - 08/2003
1CalciumIBA
08/2010
1SodiumIBA
08/2010
1PotassiumIBA
08/2010
1Desipramine (Pertofrane)FDA LinkGeneric
01/2010
1Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
01/2010
1Fluoxetine (Prozac)FDA LinkGeneric
01/2010
1agomelatine (S20098)IBA
01/2010
1RotenoneIBA
08/2008
1PesticidesIBA
08/2008
1GABA Plasma Membrane Transport ProteinsIBA
10/2005
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
11/2004
1Egtazic Acid (EGTA)IBA
11/2004
1Purinergic P1 Receptors (Adenosine Receptor)IBA
11/2004
11,3-dipropyl-8-cyclopentylxanthineIBA
08/2003
1benzyloxyaspartate (TBOA)IBA
08/2003
1Pharmaceutical PreparationsIBA
08/2003
1Neuroprotective AgentsIBA
08/2003
1Amino Acid Transport System X-AG (Glutamate Transporter)IBA
08/2003
1Glycine Plasma Membrane Transport ProteinsIBA
03/2003

Therapy/Procedure

2Deep Brain Stimulation
06/2006 - 03/2005
1Therapeutics
01/2010